Antibody neutralization of vascular endothelial growth factor (VEGF) fails to attenuate vascular permeability and brain edema in experimental pneumococcal meningitis

被引:20
作者
van der Flier, M
Coenjaerts, FE
Mwinzi, PN
Rijkers, E
Ruyken, M
Scharringa, J
Kimpen, JLL
Hoepelman, AIM
Geelen, SPM
机构
[1] Univ Utrecht, Med Ctr, Wilhelmina Childrens Hosp, NL-3508 AB Utrecht, Netherlands
[2] Univ Utrecht, Med Ctr, Eijkman Winkler Inst Microbiol, NL-3584 CX Utrecht, Netherlands
[3] Univ Utrecht, Med Ctr, Dept Med, Div Acute Med & Infect Dis, NL-3584 CX Utrecht, Netherlands
关键词
brain edema; bacterial meningitis; (VEGF) vascular endothelial gro vth factor; vascular permeability;
D O I
10.1016/j.jneuroim.2004.11.013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To determine the contribution of vascular endothelial growth factor (VEGF) to cerebral edema formation in bacterial meningitis, we used a VEGF neutralizing antibody to block VEGF in rabbits, following induction of meningitis by intracisternal inoculation with 10(9) heat-killed pneumococci. At 8 h, cerebrospinal fluid (CSF) VEGF was significantly elevated in infected untreated animals, and correlated with CSF white blood cell (WBC) count (r-0.56, P=0.004), and brain water content (r=0.42, P=0.04). Blocking of VEGF did not attenuate brain edema, blood-brain barrier disruption, or CSF pleocytosis. The functional role of VEGF in the pathophysiology of BM remains elusive. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:170 / 177
页数:8
相关论文
共 44 条
[1]  
Barleon B, 1997, J BIOL CHEM, V272, P10382
[2]   Fiber type-specific differential expression of angiogenic factors in response to chronic hindlimb ischemia [J].
Cherwek, DH ;
Hopkins, MB ;
Thompson, MJ ;
Annex, BH ;
Taylor, DA .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 279 (03) :H932-H938
[3]   Angiogenesis modulation in cancer research: Novel clinical approaches [J].
Cristofanilli, M ;
Charnsangavej, C ;
Hortobagyi, GN .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (06) :415-426
[4]   Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice [J].
Detmar, M ;
Brown, LF ;
Schön, MP ;
Elicker, BM ;
Velasco, P ;
Richard, L ;
Fukumura, D ;
Monsky, W ;
Claffey, KP ;
Jain, RK .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (01) :1-6
[5]   Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability [J].
Eliceiri, BP ;
Paul, R ;
Schwartzberg, PL ;
Hood, JD ;
Leng, J ;
Cheresh, DA .
MOLECULAR CELL, 1999, 4 (06) :915-924
[6]   MEASUREMENT OF EXPERIMENTALLY INDUCED BRAIN SWELLING AND SHRINKAGE [J].
ELLIOTT, KAC ;
JASPER, H .
AMERICAN JOURNAL OF PHYSIOLOGY, 1949, 157 (01) :122-129
[7]   Inhibition of vascular endothelial growth factor in the treatment of colorectal cancer [J].
Fernando, NH ;
Hurwitz, HI .
SEMINARS IN ONCOLOGY, 2003, 30 (03) :39-50
[8]   The biology of VEGF and its receptors [J].
Ferrara, N ;
Gerber, HP ;
LeCouter, J .
NATURE MEDICINE, 2003, 9 (06) :669-676
[9]   VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism [J].
Gerber, HP ;
Malik, AK ;
Solar, GP ;
Sherman, D ;
Liang, XH ;
Meng, G ;
Hong, K ;
Marsters, JC ;
Ferrara, N .
NATURE, 2002, 417 (6892) :954-958
[10]   Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade [J].
Gómez, R ;
Simón, C ;
Remohí, J ;
Pellicer, A .
ENDOCRINOLOGY, 2002, 143 (11) :4339-4348